943153-19-3Relevant academic research and scientific papers
Optimization of Preclinical Metabolism for Somatostatin Receptor Subtype 5-Selective Antagonists
Liu, Weiguo,Hussain, Zahid,Zang, Yi,Sweis, Ramzi F.,Romero, F. Anthony,Finke, Paul E.,Moningka, Remond,Bao, Jianming,Plotkin, Michael A.,Shang, Jin,Dingley, Karen H.,Salituro, Gino,Murphy, Beth Ann,Howard, Andrew D.,Ujjainwalla, Feroze,Wood, Harold B.,Duffy, Joseph L.
supporting information, p. 1088 - 1093 (2018/10/24)
A series of structurally diverse azaspirodecanone and spirooxazolidinone analogues were designed and synthesized as potent and selective somatostatin receptor subtype 5 (SSTR5) antagonists. Four optimized compounds each representing a subseries showed imp
Compounds with medicinal effects due to interaction with the glucocorticoid receptor
-
Page/Page column 13-14, (2010/11/27)
The invention provides for compounds having the structure according to the formula I
